𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stereocomplex formation between enantiomeric poly(lactic acid)s. X. Binary blends from poly(D-lactide-CO-glycolide) and poly(L-lactide-CO-glycolide)

✍ Scribed by Hideto Tsuji; Yoshito Ikada


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
779 KB
Volume
53
Category
Article
ISSN
0021-8995

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Small-molecule release from poly(D,L-lac
✍ Emily J. Pollauf; Kyekyoon Kevin Kim; Daniel W. Pack πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 402 KB

Addition of biodegradable polymer shells surrounding polymeric, drugloaded microparticles offers the opportunity to control drug release rates. A novel fabrication method was used to produce microparticles with precise control of particle diameter and the thickness of the polymer shell. The effect o

Biomimetic, bioactive etheric polyphosph
✍ Meng Deng; Lakshmi S. Nair; Syam P. Nukavarapu; Sangamesh G. Kumbar; Justin L. B πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 452 KB

## Abstract The long‐term goal of this work is to develop biomimetic polymer‐based systems for bone regeneration that both allow for neutral pH degradation products and have the ability to nucleate bonelike apatite. In this study, the etheric biodegradable polyphosphazene, poly[(50%ethyl glycinato)

Paclitaxel release from single and doubl
✍ Luciana Lisa Lao; Subbu S. Venkatraman πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 274 KB

## Abstract Our laboratory has been developing a completely biodegradable coronary stent which is made of bilayers of biodegradable polyesters. This article presents the preliminary work done to exploit the drug delivery potential of such a polymeric stent. An antiproliferative drug (paclitaxel) wa

Poly(D,L-lactide-co-glycolide acid) nano
✍ Gvili Koby; Benny Ofra; Danino Dganit; Machluf Marcelle πŸ“‚ Article πŸ“… 2007 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 495 KB πŸ‘ 1 views

## Abstract When designing a nonviral gene delivery system based on polymeric nanoparticles (NPs), it is important to keep in mind obstacles associated with future clinical applications. Simplifying the procedure of NPs production and taking toxicity into account are the most important issues that